Literature DB >> 28625572

Nanoparticle Technology: Having Impact, but Needing Further Optimization.

S Moein Moghimi1, Ernst Wagner2.   

Abstract

Mesh：

Year:  2017        PMID： 28625572      PMCID： PMC5498916          DOI： 10.1016/j.ymthe.2017.06.007

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  33 in total

1.  Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.

Authors:  Robert Kuo; Eiji Saito; Stephen D Miller; Lonnie D Shea
Journal:  Mol Ther       Date:  2017-04-10       Impact factor: 11.454

Review 2.  Lipid Nanoparticle Systems for Enabling Gene Therapies.

Authors:  Pieter R Cullis; Michael J Hope
Journal:  Mol Ther       Date:  2017-04-13       Impact factor: 11.454

Review 3.  The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.

Authors:  Ricardo Titze-de-Almeida; Catherine David; Simoneide Souza Titze-de-Almeida
Journal:  Pharm Res       Date:  2017-04-07       Impact factor: 4.200

4.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Authors:  Thomas J Anchordoquy; Yechezkel Barenholz; Diana Boraschi; Michael Chorny; Paolo Decuzzi; Marina A Dobrovolskaia; Z Shadi Farhangrazi; Dorothy Farrell; Alberto Gabizon; Hamidreza Ghandehari; Biana Godin; Ninh M La-Beck; Julia Ljubimova; S Moein Moghimi; Len Pagliaro; Ji-Ho Park; Dan Peer; Erkki Ruoslahti; Natalie J Serkova; Dmitri Simberg
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

5.  A Triple-Fluorophore-Labeled Nucleic Acid pH Nanosensor to Investigate Non-viral Gene Delivery.

Authors:  David R Wilson; Denis Routkevitch; Yuan Rui; Arman Mosenia; Karl J Wahlin; Alfredo Quinones-Hinojosa; Donald J Zack; Jordan J Green
Journal:  Mol Ther       Date:  2017-05-04       Impact factor: 11.454

6.  Dual Functional LipoMET Mediates Envelope-type Nanoparticles to Combinational Oncogene Silencing and Tumor Growth Inhibition.

Authors:  Kai Shi; Yi Zhao; Lei Miao; Andrew Satterlee; Matthew Haynes; Cong Luo; Sara Musetti; Leaf Huang
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

7.  Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Authors:  Dunja Sobot; Simona Mura; Marie Rouquette; Branko Vukosavljevic; Fanny Cayre; Eric Buchy; Grégory Pieters; Sébastien Garcia-Argote; Maike Windbergs; Didier Desmaële; Patrick Couvreur
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

Review 8.  Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.

Authors:  Shoshy Mizrahy; Inbal Hazan-Halevy; Niels Dammes; Dalit Landesman-Milo; Dan Peer
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454

9.  HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.

Authors:  Yvonn Heun; Kristin Pogoda; Martina Anton; Joachim Pircher; Alexander Pfeifer; Markus Woernle; Andrea Ribeiro; Petra Kameritsch; Olga Mykhaylyk; Christian Plank; Florian Kroetz; Ulrich Pohl; Hanna Mannell
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

10.  Just so stories: the random acts of anti-cancer nanomedicine performance.

Authors:  Seyed Moein Moghimi; Zahra Shadi Farhangrazi
Journal:  Nanomedicine       Date:  2014-11       Impact factor: 5.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.